PRO_SELECT: combining structure-based drug design and array-based chemistry for rapid lead discovery. 2. The development of a series of highly potent and selective factor Xa inhibitors.

Source:http://linkedlifedata.com/resource/pubmed/id/11881991

J. Med. Chem. 2002 Mar 14 45 6 1221-32

Download in:

View as

General Info

PMID
11881991